RNA Analytical/Quality Videos
-
Master mRNA Manufacturing, Purification, And Plasmid DNA Processes
3/12/2025
Whether you're a pro or a beginner, revolutionize your process and achieve excellence today by enhancing your mRNA manufacturing skills with valuable insights and tools.
-
A Double-Edged Sword? Defining "Efficiency" In mRNA Process Development
8/22/2024
In this clip from a recent Advancing RNA LIVE event, panelists address a question about where the best opportunities exist upstream and/or downstream to increase mRNA manufacturing efficiencies.
-
Breaking New Ground: MHRA Embraces A Future With Patient-Specific mRNA
6/24/2025
In this Advancing RNA clip, panelists Ulrike Jägle and Tiffany Lucas unpack the benefits they see to the MHRA's new guidance on mRNA cancer immunotherapies, including the agency’s support for bioinformatics approaches and its burgeoning framework for developing and justifying a truly personalized medicine.
-
LBA Vs. LC-MS: Competing Technologies At A Development Crossroad
2/6/2025
Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.
-
Sustainable Vaccine Manufacturing: Securing The Future Of Global Health
7/22/2025
Explore how next-gen technologies, from mRNA platforms to digital tools, are transforming vaccine manufacturing to make it more sustainable, flexible, and accessible.
-
Don't Ignore These Functional Areas In Your RNA Therapeutic's Regulatory Story
5/10/2024
Explore two functional areas that Advancing RNA panelists consider most essential to telling an RNA product’s “story” thoroughly to regulators.
-
Development Of A Mitra Tip Extraction Assay Coupled With LC-MSMS
1/15/2025
Watch this rundown of a novel method for quantifying L-Citrulline, L-Arginine, and L-Argininosuccinic acid using Mitra tip extraction coupled with LC-MS/MS for enhanced accuracy and reproducibility.
-
Taming dsRNA Via Innovation In The Supply Chain
10/15/2025
Here, Ethris’ Christan Dohmen and Tune Therapeutics’ Stu Sundseth share their take on the most meaningful strategies for reducing dsRNA production. But this discussion also probes a deeper question: Is dsRNA still the most relevant impurity the industry should be chasing, or should focus shift to other contaminants?
-
What The EMA Guidance Means For mRNA: Progress, Limitations, And Future Directions
6/24/2025
Advancing RNA panelists Tiffany Lucas and Ulrike Jägle home in on the EMA’s guidance for mRNA vaccine quality, sharing their initial thoughts on the guidance’s strengths, while also addressing its limitations for those of us who may be working with mRNA in a therapeutic context.
-
3 Must-Improve Areas in mRNA Process Development
10/15/2025
In this Advancing RNA Live clip, panelists Stu Sundseth, Marc Wolfgang, and Christian Dohmen each provide their take on the most critical areas for improvement in mRNA process development.